-+ 0.00%
-+ 0.00%
-+ 0.00%

Definium Therapeutics Q1 EPS $(0.71) Misses $(0.48) Estimate. Cash And Equivalents Of $373.4M

Benzinga·05/07/2026 20:09:50
Listen to the news
Definium Therapeutics (NASDAQ:DFTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.48) by 47.92 percent. This is a 102.86 percent decrease over losses of $(0.35) per share from the same period last year.